The primary role of our Board is to protect and enhance medium to long term shareholder value through the provision of strategic direction and corporate governance of Vitura Health Limited. Bringing a wealth of knowledge and experience, our Board carries a diverse background of expertise.
Our Board
Robert Iervasi
Independent Chair and Non- Executive Director
Robert Iervasi was appointed Chair of Vitura on 13 February 2024. He is an astute leader in the consumer products industry, leading Asahi Beverages as Group Chief Executive Officer and Board Director from 2019 - 2023, and as Group Chief Operating Officer, Group CFO & General Counsel for the preceding eight years. Before joining Asahi, he was the Legal, Tax, Treasury & Risk Director at Cadbury Schweppes and a principal legal advisor at Coles Group Limited. His legal experience extends to private practice, covering litigation, tax, general corporate and mergers & acquisition.
He has a track record of delivering revenue and cost synergies, executing strategic opportunities, and driving profitability and growth across multiple categories, brands, and channels.
Robert holds an LLB (Hons) and BCom (Hons) from Monash University, completed the Senior Executive Program at London Business School and further study focused on exploiting disruption in a digital world. A Graduate of the Australian Institute of Company Directors, he was selected as a Young Executive 2012 by the Australian Financial Review.
Beyond Vitura, he sits on the Board of SPC Global as Non-Executive Director, Luv-A-Duck as Chairman and Charters Papers as Executive Chairman.
Robert Iervasi was appointed Chair of Vitura on 13 February 2024. He is an astute leader in the consumer products industry, leading Asahi Beverages as Group Chief Executive Officer and Board Director from 2019 - 2023, and as Group Chief Operating Officer, Group CFO & General Counsel for the preceding eight years. Before joining Asahi, he was the Legal, Tax, Treasury & Risk Director at Cadbury Schweppes and a principal legal advisor at Coles Group Limited. His legal experience extends to private practice, covering litigation, tax, general corporate and mergers & acquisition.
He has a track record of delivering revenue and cost synergies, executing strategic opportunities, and driving profitability and growth across multiple categories, brands, and channels.
Robert holds an LLB (Hons) and BCom (Hons) from Monash University, completed the Senior Executive Program at London Business School and further study focused on exploiting disruption in a digital world. A Graduate of the Australian Institute of Company Directors, he was selected as a Young Executive 2012 by the Australian Financial Review.
Beyond Vitura, he sits on the Board of SPC Global as Non-Executive Director, Luv-A-Duck as Chairman and Charters Papers as Executive Chairman.
Dr. Marcia Walker
Independent Non- Executive Director
Dr Marcia Walker was appointed a Non-Executive Director of Vitura on 16 December 2021, was Acting Chair from 11 April 2022 to 24 February 2023 and is Interim Chair from the 6 September 2023. Dr Marcia brings significant experience in medical governance, having formerly served on the board of the New Zealand Medical Association and as a member of the General Practitioner Council of the NZMA. She is also a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and Treasurer for the New Zealand Resident Doctors Association. Dr Marcia received a Bachelor of Medicine and a Bachelor of Surgery / Chirurgery from the University of Auckland and is a fellow of the Royal New Zealand College of General Practitioners. She also acts as the Medical Director of The Cosmetic Clinic New Zealand.
Dr Marcia Walker was appointed a Non-Executive Director of Vitura on 16 December 2021, was Acting Chair from 11 April 2022 to 24 February 2023 and is Interim Chair from the 6 September 2023. Dr Marcia brings significant experience in medical governance, having formerly served on the board of the New Zealand Medical Association and as a member of the General Practitioner Council of the NZMA. She is also a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and Treasurer for the New Zealand Resident Doctors Association. Dr Marcia received a Bachelor of Medicine and a Bachelor of Surgery / Chirurgery from the University of Auckland and is a fellow of the Royal New Zealand College of General Practitioners. She also acts as the Medical Director of The Cosmetic Clinic New Zealand.
Jenelle Frewen
Independent Non-Executive Director
Jenelle Frewen was appointed as an Independent Non-Executive Director of Vitura on 12 September 2022. Jenelle is an accomplished government strategist and adviser with more than two decades’ experience spanning complex policy development and implementation in highly regulated industries. She has led several federal and state political campaigns and advised a range of business clients on public affairs and regulatory policy. She has experience working at all three levels of government in Australia and in new areas of policy-making in technology, broadband and cyber safety. Jenelle also spent time in her early career working as a communications and media adviser in the private sector in Australia and was a senior aide in municipal government in the United States. She is currently Principal Consultant with the Canberra-based advisory firm, Precision Public Affairs. Jenelle obtained a Bachelor of Economics and a Bachelor of Arts with Honours from Monash University and holds a post-graduate diploma in Governance and Public Policy.
Jenelle Frewen was appointed as an Independent Non-Executive Director of Vitura on 12 September 2022. Jenelle is an accomplished government strategist and adviser with more than two decades’ experience spanning complex policy development and implementation in highly regulated industries. She has led several federal and state political campaigns and advised a range of business clients on public affairs and regulatory policy. She has experience working at all three levels of government in Australia and in new areas of policy-making in technology, broadband and cyber safety. Jenelle also spent time in her early career working as a communications and media adviser in the private sector in Australia and was a senior aide in municipal government in the United States. She is currently Principal Consultant with the Canberra-based advisory firm, Precision Public Affairs. Jenelle obtained a Bachelor of Economics and a Bachelor of Arts with Honours from Monash University and holds a post-graduate diploma in Governance and Public Policy.
Guy Headley
Chief Commercial Officer and Executive Director
Guy Headley was appointed Executive Director and Chief Commercial Officer of Vitura on 16 December 2021. Guy has operated in the Australian medical cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last five years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director and Chairman of the Emerging Therapeutics Association of Australia.
Guy Headley was appointed Executive Director and Chief Commercial Officer of Vitura on 16 December 2021. Guy has operated in the Australian medical cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last five years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director and Chairman of the Emerging Therapeutics Association of Australia.